[HTML][HTML] Liver tests increase on abiraterone acetate in men with metastatic prostate cancer: Natural history, management and outcome
E Colomba, G Marret, G Baciarello, P Lavaud… - European Journal of …, 2020 - Elsevier
Background Abiraterone acetate (abiraterone) combined with prednisone is a standard of
care in metastatic castration-resistant prostate cancer. Recently, benefit in overall survival …
care in metastatic castration-resistant prostate cancer. Recently, benefit in overall survival …
Treatment-emergent co-morbidities and survival in patients with metastatic castration-resistant prostate cancer receiving abiraterone or enzalutamide
YT Lin, YC Huang, CK Liu, TS Lee, M Chen… - Frontiers in …, 2021 - frontiersin.org
Secondary hormone therapy, abiraterone and enzalutamide, has improved outcomes for
metastatic castration-resistant prostate cancer (mCRPC) and prolonged patients' lives …
metastatic castration-resistant prostate cancer (mCRPC) and prolonged patients' lives …
Fatal fulminant hepatitis in a patient taking abiraterone acetate: a case report
D Akpokavie, C Gubert, I Abdelli, AOM Stern… - Frontiers in …, 2023 - frontiersin.org
Abiraterone acetate is a steroidal inhibitor of cytochrome P450 17A1 indicated in the
treatment of metastatic prostate cancer. This report examines the case of a 66-year-old …
treatment of metastatic prostate cancer. This report examines the case of a 66-year-old …
The modern therapeutic & imaging landscape of metastatic prostate cancer: a primer for radiologists
Prostate cancer represents one of the leading causes of cancer-related mortality in the
United States and the most common cancer among men. Treatment paradigms for the …
United States and the most common cancer among men. Treatment paradigms for the …
Profils d'effets indésirables sous abiratérone et enzalutamide: analyse descriptive des données de la base nationale de pharmacovigilance
LM Scailteux, C Lacroix, S Bergeron, F Despas… - Therapies, 2021 - Elsevier
Résumé Objectif L'objectif de cette étude était de décrire le profil d'effets indésirables de
l'abiratérone et l'enzalutamide, à partir des cas enregistrés par les centres régionaux de …
l'abiratérone et l'enzalutamide, à partir des cas enregistrés par les centres régionaux de …
A case analysis of acute-on-chronic liver failure caused by abiraterone
Z **ao, J Dai, W Yao, S MA - China Pharmacy, 2023 - pesquisa.bvsalud.org
Abiraterone is commonly used as a targeted drug for the treatment of prostate cancer, which
commonly causes adverse drug reactions (ADR), including abnormal liver function, fatigue …
commonly causes adverse drug reactions (ADR), including abnormal liver function, fatigue …
阿比特龙致慢加急性肝衰竭 1 例病例分析
肖准， 代静慧， 姚伟丽， 马素** - **药房, 2023 - journal.china-pharmacy.com
阿比特龙是治疗前列腺癌的常用靶向药物, 其常见药品不良反应(ADR) 包括肝功能异常, 疲乏,
恶心, 水肿等. 本文报道了1 例入住河南中医药大学第一附属医院的78 岁既往有乙型肝炎 …
恶心, 水肿等. 本文报道了1 例入住河南中医药大学第一附属医院的78 岁既往有乙型肝炎 …